Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.

Scholz, M

Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Mar 2011 - 681-688 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1569-8041

10.1093/annonc/mdq408 doi


Algorithms
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bleomycin--adverse effects
Cyclophosphamide--adverse effects
Dacarbazine--adverse effects
Doxorubicin--adverse effects
Etoposide--adverse effects
Glyoxal--adverse effects
Hodgkin Disease--drug therapy
Humans
Ifosfamide--adverse effects
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute--chemically induced
Lymphoma, Non-Hodgkin--chemically induced
Myelodysplastic Syndromes--chemically induced
Neoplasms, Second Primary--chemically induced
Prednimustine--adverse effects
Prednisone--adverse effects
Procarbazine--adverse effects
Proportional Hazards Models
Randomized Controlled Trials as Topic
Risk Assessment
Treatment Outcome
Vinblastine--adverse effects
Vincristine--adverse effects